Clinical management of eosinophilic esophagitis – a nationwide survey among gastroenterologists in Germany

Abstract Background Eosinophilic esophagitis (EoE) is an increasingly recognized immune-mediated esophageal disease and a common cause for dysphagia and food bolus obstruction. The aim of this study was to evaluate the current clinical management of EoE among adult gastroenterologists in Germany. Methods We performed a cross-sectional study of 1393 adult gastroenterologists using a questionnaire containing 22 questions to general, diagnostic, and therapeutic aspects of EoE. The self-administered online survey was conducted between November 2017 and February 2018. Data capture and analysis was performed using SurveyMonkey. Results The overall responder rate was 29.6 %. More than half of the responders (54.9 %) felt to observe a significant increase of EoE patients. The EREFS score was mostly either unknown (44.3 %) or not routinely used (52.2 %). If EoE was suspected, most responders obtained multiple esophageal biopsies (n = 3 – 4: 35.7 %; n > 4: 61.6 %). The preferred primary treatment was proton pump inhibitors (PPI) in 37.2 % and topical steroids in 35.0 % of responders. PPI regimens were highly diverse, with only half of responders using high-dose PPI regimens. Allergy testing was often initiated (always 25.4 %, sometimes 48.9 %). The most common dietary therapy was 6-food elimination diet (52 %), followed by allergy test-directed diets (16 %) and 2-food elimination diet (16.5 %). The majority of responders indicated a need for long-term treatment (i. e., 23 % of responders in > 50 % their patients and 47.7 % of responders in 25 – 50 % of their patients). Conclusions Among gastroenterologists in Germany, substantial variation in the adherence to published EoE guidelines appears to exist. This indicates the need for intensified education and national guidelines in order to optimize and harmonize the clinical management of EoE patients.

[1]  F. Lammert,et al.  Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial. , 2019, Gastroenterology.

[2]  A. Schoepfer,et al.  Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5‐Year Follow‐up Period In Adult Patients , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  Joy W. Chang,et al.  Management of eosinophilic esophagitis is often discordant with guidelines and not patient-centered: results of a survey of gastroenterologists. , 2019, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[4]  Kelley E. Capocelli,et al.  Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. , 2018, Gastroenterology.

[5]  A. Bredenoord,et al.  The Natural Course of Eosinophilic Esophagitis and Long‐Term Consequences of Undiagnosed Disease in a Large Cohort , 2018, The American Journal of Gastroenterology.

[6]  E. Dellon,et al.  Management of Esophageal Food Impaction Varies Among Gastroenterologists and Affects Identification of Eosinophilic Esophagitis , 2018, Digestive Diseases and Sciences.

[7]  Jason D. Eckmann,et al.  Efficacy of Atopy Patch Testing in Directed Dietary Therapy of Eosinophilic Esophagitis: A Pilot Study , 2018, Digestive Diseases and Sciences.

[8]  A. Bredenoord,et al.  Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20‐year results from a nationwide pathology database , 2018, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[9]  I. Hirano,et al.  Eosinophilic Esophagitis Reference Score Accurately Identifies Disease Activity and Treatment Effects in Children , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  E. Dellon,et al.  Epidemiology and Natural History of Eosinophilic Esophagitis. , 2017, Gastroenterology.

[11]  E. Dellon,et al.  Lack of Knowledge and Low Readiness for Health Care Transition in Eosinophilic Esophagitis and Eosinophilic Gastroenteritis , 2017, Journal of pediatric gastroenterology and nutrition.

[12]  A. Bredenoord,et al.  Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults , 2017, United European gastroenterology journal.

[13]  A. Bredenoord,et al.  The Endoscopic Reference Score shows modest accuracy to predict histologic remission in adult patients with eosinophilic esophagitis , 2016, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[14]  J. Molina-Infante,et al.  The efficacy of step‐down therapy in adult patients with proton pump inhibitor‐responsive oesophageal eosinophilia , 2016, Alimentary pharmacology & therapeutics.

[15]  Nicholas J Shaheen,et al.  Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in Diagnosis and Determining Response to Treatment. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  M. Zwahlen,et al.  Escalating incidence of eosinophilic esophagitis in Canton of Vaud, Switzerland, 1993–2013: a population‐based study , 2015, Allergy.

[17]  Christopher F. Martin,et al.  Health-Care Utilization, Costs, and the Burden of Disease Related to Eosinophilic Esophagitis in the United States , 2015, The American Journal of Gastroenterology.

[18]  R. Erichsen,et al.  The increasing incidence and prevalence of eosinophilic oesophagitis outpaces changes in endoscopic and biopsy practice: national population‐based estimates from Denmark , 2015, Alimentary pharmacology & therapeutics.

[19]  M. Vieth,et al.  A randomised, double-blind trial comparing budesonide formulations and dosages for short-term treatment of eosinophilic oesophagitis , 2015, Gut.

[20]  A. Bredenoord,et al.  Evaluating the Endoscopic Reference Score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability , 2014, Endoscopy.

[21]  A. Schoepfer,et al.  Swallowed topical corticosteroids reduce the risk for long‐lasting bolus impactions in eosinophilic esophagitis , 2014, Allergy.

[22]  M. Mearin,et al.  Management Guidelines of Eosinophilic Esophagitis in Childhood , 2014, Journal of pediatric gastroenterology and nutrition.

[23]  A. Schoepfer,et al.  Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. , 2013, Gastroenterology.

[24]  E. Dellon,et al.  Clinical Guideline : Evidenced Based Approach to the Diagnosis and Management of Esophageal Eosinophilia and Eosinophilic Esophagitis ( EoE ) , 2013 .

[25]  A. Lucendo,et al.  Empiric 6-food elimination diet induced and maintained prolonged remission in patients with adult eosinophilic esophagitis: a prospective study on the food cause of the disease. , 2013, The Journal of allergy and clinical immunology.

[26]  I. Hirano,et al.  Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. , 2012, Gastroenterology.

[27]  M. Heckman,et al.  Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system , 2012, Gut.

[28]  A. Schoepfer,et al.  Eosinophilic esophagitis: updated consensus recommendations for children and adults. , 2011, The Journal of allergy and clinical immunology.

[29]  Anand Gupte,et al.  Eosinophilic esophagitis. , 2009, World journal of gastroenterology.

[30]  A. Straumann,et al.  Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. , 2007, Gastroenterology.